PLx Pharma Winddown Corp. — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$8.2M

Net Income/Loss (FY2021)

-$46.1M

Total Assets (FY2021)

$76.6M

Total Equity (FY2021)

$51.7M

Cash Flows from Operating Activities (FY2021)

-$32.1M

Source: PLx Pharma Winddown Corp. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.